WallStreetZenWallStreetZen

NYSE: DGX
Quest Diagnostics Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for DGX

Based on 11 analysts offering 12 month price targets for Quest Diagnostics Inc

Min Forecast
$178.00-0.98%
Avg Forecast
$188.00+4.58%
Max Forecast
$200.00+11.25%

Should I buy or sell DGX stock?

Based on 11 analysts offering ratings for Quest Diagnostics Inc.

Hold
Strong Buy
1 analysts 9.09%
Buy
2 analysts 18.18%
Hold
8 analysts 72.73%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Our proven Zen Rating quant model agrees with analyst consensus with a "Hold" rating. Learn More

Be the first to know when Wall Street analysts revise their DGX stock forecasts and price targets.

DGX stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-07-23
lockedlocked$00.00+00.00%2025-07-23
lockedlocked$00.00+00.00%2025-07-23
lockedlocked$00.00+00.00%2025-05-06
lockedlocked$00.00+00.00%2025-04-28
Barclays
Bottom 5%
5
HoldMaintains$185.00+2.91%2025-04-23
Evercore ISI Group
Bottom 7%
7
HoldMaintains$180.00+0.13%2025-04-23
Baird
Top 23%
78
BuyMaintains$194.00+7.92%2025-04-23
Mizuho
Top 9%
92
BuyMaintains$189.00+5.13%2025-04-09
Redburn Atlantic
Top 46%
55
Strong BuyInitiates Coverage On$195.00+8.47%2025-04-02

1 of 2

Forecast return on equity

Is DGX forecast to generate an efficient return?

Company
19.76%
Industry
71.05%
Market
-47.51%
DGX's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is DGX forecast to generate an efficient return on assets?

Company
8.94%
Industry
21.55%
DGX is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

DGX earnings per share forecast

What is DGX's earnings per share in the next 3 years based on estimates from 10 analysts?

Avg 1 year Forecast
$9.74+14.97%
Avg 2 year Forecast
$10.42+23.05%
Avg 3 year Forecast
$11.19+32.07%
DGX's earnings are forecast to... subscribe to Premium to read more.
Forecast High Earnings Growth Forecast

DGX revenue forecast

What is DGX's revenue in the next 3 years based on estimates from 9 analysts?

Avg 1 year Forecast
$10.9B+3.14%
Avg 2 year Forecast
$11.2B+6.58%
Avg 3 year Forecast
$11.6B+10.71%
DGX's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

DGX earnings growth forecast

How is DGX forecast to perform vs Diagnostics & Research companies and vs the US market?

Company
9.65%
Industry
15.47%
Market
15.23%
DGX's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Industry Forecast
DGX's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Market Forecast
DGX's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Savings Rate Forecast

DGX revenue growth forecast

How is DGX forecast to perform vs Diagnostics & Research companies and vs the US market?

Company
3.4%
Industry
5.29%
Market
10.92%
DGX's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
DGX's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

DGX vs Diagnostic & Research Stocks

TickerPricePrice TargetUp/downsideConsensus
DGX$179.77$188.00+4.58%Hold
NTRA$163.02$202.67+24.32%Strong Buy
LH$270.38$294.89+9.06%Strong Buy
WAT$291.55$366.89+25.84%Buy
ILMN$100.11$112.75+12.63%Hold
View Top Diagnostic & Research Stocks

Quest Diagnostics Stock Forecast FAQ

Is Quest Diagnostics Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 11 Wall Street analysts covering (NYSE: DGX) stock is to Hold DGX stock.

Out of 11 analysts, 1 (9.09%) are recommending DGX as a Strong Buy, 2 (18.18%) are recommending DGX as a Buy, 8 (72.73%) are recommending DGX as a Hold, 0 (0%) are recommending DGX as a Sell, and 0 (0%) are recommending DGX as a Strong Sell.

If you're new to stock investing, here's how to buy Quest Diagnostics stock.

What is DGX's earnings growth forecast for 2025-2027?

(NYSE: DGX) Quest Diagnostics's forecast annual earnings growth rate of 9.65% is not forecast to beat the US Diagnostics & Research industry's average forecast earnings growth rate of 15.47%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 15.23%.

Quest Diagnostics's earnings in 2025 is $950,000,000.On average, 10 Wall Street analysts forecast DGX's earnings for 2025 to be $1,088,891,939, with the lowest DGX earnings forecast at $1,081,332,674, and the highest DGX earnings forecast at $1,096,987,956. On average, 10 Wall Street analysts forecast DGX's earnings for 2026 to be $1,165,446,267, with the lowest DGX earnings forecast at $1,123,825,582, and the highest DGX earnings forecast at $1,195,392,584.

In 2027, DGX is forecast to generate $1,250,912,923 in earnings, with the lowest earnings forecast at $1,204,338,460 and the highest earnings forecast at $1,304,979,556.

What is DGX's revenue growth forecast for 2025-2027?

(NYSE: DGX) Quest Diagnostics's forecast annual revenue growth rate of 3.4% is not forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 5.29%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.92%.

Quest Diagnostics's revenue in 2025 is $10,522,000,000.On average, 9 Wall Street analysts forecast DGX's revenue for 2025 to be $1,213,607,840,065, with the lowest DGX revenue forecast at $1,205,479,058,668, and the highest DGX revenue forecast at $1,218,178,287,745. On average, 9 Wall Street analysts forecast DGX's revenue for 2026 to be $1,254,045,544,623, with the lowest DGX revenue forecast at $1,241,665,124,176, and the highest DGX revenue forecast at $1,270,537,936,642.

In 2027, DGX is forecast to generate $1,302,646,584,020 in revenue, with the lowest revenue forecast at $1,296,028,537,312 and the highest revenue forecast at $1,310,906,198,843.

What is DGX's forecast return on assets (ROA) for 2025-2028?

(NYSE: DGX) forecast ROA is 8.94%, which is lower than the forecast US Diagnostics & Research industry average of 21.55%.

What is DGX's Price Target?

According to 11 Wall Street analysts that have issued a 1 year DGX price target, the average DGX price target is $188.00, with the highest DGX stock price forecast at $200.00 and the lowest DGX stock price forecast at $178.00.

On average, Wall Street analysts predict that Quest Diagnostics's share price could reach $188.00 by Jul 23, 2026. The average Quest Diagnostics stock price prediction forecasts a potential upside of 4.58% from the current DGX share price of $179.77.

What is DGX's Earnings Per Share (EPS) forecast for 2025-2027?

(NYSE: DGX) Quest Diagnostics's current Earnings Per Share (EPS) is $8.47. On average, analysts forecast that DGX's EPS will be $9.74 for 2025, with the lowest EPS forecast at $9.67, and the highest EPS forecast at $9.81. On average, analysts forecast that DGX's EPS will be $10.42 for 2026, with the lowest EPS forecast at $10.05, and the highest EPS forecast at $10.69. In 2027, DGX's EPS is forecast to hit $11.19 (min: $10.77, max: $11.67).

What is DGX's forecast return on equity (ROE) for 2025-2028?

(NYSE: DGX) forecast ROE is 19.76%, which is considered weak.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.